Cisplatin Package Insert

Karmustin - Wikipedia
Karmustin ili BCNU (bis-hloroetilnitrozoureja) je β-hloro-nitrozourejno jedinjenje strodno sa azotnim iperitom, koje se koristi kao alkilirajući agens u hemoterapiji. Kao dialkilirajući agens, BCNU ima sposobnost formiranja veza između DNK lanaca, čime se onemogućava DNK replikacija i DNK transkripcija. ... Read Article

CISplatin Injection - Food And Drug Administration
Cisplatin Injection infusion concentrate must be further diluted prior to administration (see DOSAGE AND ADMINISTRATION, All Patients The active ingredient, cisplatin, is a yellow to orange crystalline powder with the molecular ... Fetch Full Source

PACKAGE INSERT TEMPLATE FOR CARBOPLATIN SOLUTION FOR ...
Carboplatin is a cisplatin analog with similar antineoplastic activity, but with a different adverse effect profile than cisplatin. Carboplatin has a carboxycyclobutane moiety replacing the chloride Date of Revision of Package Insert [ day/month/year ] ... Fetch Here

HIGHLIGHTS OF PRESCRIBING INFORMATION Interstitial Lung ...
For HYCAMTIN for injection in combination with cisplatin, reduce the dose to 0.6 mg/m2/day (and further to 0.45 mg/m2 if necessary) for: febrile neutropenia (defined as neutrophil counts less than 1,000/mm3 with temperature of greater than or equal to 38.0 C (100.4 F) or administer G-CSF starting no sooner than 24 hours following the last dose ... Read Document

HIGHLIGHTS OF PRESCRIBING INFORMATION INDICATIONS AND USAGE
Therapy with cisplatin, serum creatinine, serum potassium, serum calcium, and serum magnesium should be carefully 0monitored (Grade 3/4 serum creatinine toxicity for Gemcitabine for Injection plus cisplatin was 5% versus 2% for cisplatin alone). ... View This Document

Wikipedia Talk:WikiProject Pharmacology/Archive 7
This is an archive of past discussions. Do not edit the contents of this page. If you wish to start a new discussion or revive an old one, please do so on the current talk page. ... Read Article

ToposarTM - Pfizer
Reduced drug total body clearance. Prior to use of cisplatin may also result in a decrease of etoposide total body clearance in children. ToposarTM 817 607 000 etoposide injection, USP WARNINGS TOPOSAR (etoposide injection, USP) should be administered under the supervision of a qualified physician experienced in the use of cancer ... Retrieve Full Source

Paclitaxel-Pack Insert-USA-B2 Circulation No. 1 Paclitaxel ...
Cisplatin 75 mg/m2 or cyclophosphamide 750 mg/m2 followed by cisplatin 75 mg/m2 for 6 courses. In both studies, patients treated with paclitaxel in combination with cisplatin had significantly higher response rate, longer time to progression, and longer survival time compared with standard therapy. ... Read Document

HIGHLIGHTS OF PRESCRIBING INFORMATION ...
Day cycle in combination with cisplatin 100mg/m2 administered intravenously on Day 1 after GEMZARadministration. 21-dayschedule The recommended dosage of GEMZARis 1250mg/m2intravenously over 30 minutes on Days 1 and 8 of each 21-day cycle in combination with cisplatin 100mg/m2administered intravenously on Day 1 after GEMZARadministration. ... View Document

PACKAGE LEAFLET: INFORMATION FOR THE USER Cisplatin 1mg/ml ...
PACKAGE LEAFLET: INFORMATION FOR THE USER Cisplatin 1mg/ml Concentrate for Solution for Infusion Cisplatin The name of your medicine is ‘Cisplatin 1 mg/ml Concentrate for Solution for Infusion’ but in the rest of the leaflet it will be called “Cisplatin Injection”. ... Fetch Document

HIGHLIGHTS OF PRESCRIBING INFORMATION - Genentech
Herceptin is indicated, in combination with cisplatin and capecitabine or 5-fluorouracil, for the • Do not substitute Herceptin (trastuzumab) for or with ado-trastuzumab emtansine. Adjuvant Treatment, Breast Cancer . ... Retrieve Doc

Nimotuzumab - Wikipedia
In April 2014, Daiichi Sankyo announced that it was halting a multicenter, randomized, double-blind, placebo-controlled Phase III study investigating nimotuzumab for first-line therapy in patients with unresectable and locally advanced squamous cell lung cancer, due to safety issues in certain patients who received a combination of cisplatin ... Read Article

HIGHLIGHTS OF PRESCRIBING INFORMATION ...
ALIMTA®is a folate analog metabolic inhibitor indicated: • in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic, non-squamous, non-small ... Retrieve Doc

CYTOXAN (cyclophosphamide For Injection, USP) CYTOXAN Tablets ...
Was compared with paclitaxel, each in combination with cisplatin, for the treatment of advanced ovarian carcinoma, 154 (28%) of 552 patients who received cyclophosphamide plus cisplatin were 65 years or older. ... Retrieve Content

Rx Only PLATINOL
Rx only . PLATINOL ® (cisplatin for injection, USP) WARNING . PLATINOL (cisplatin for injection, USP) should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. ... Content Retrieval

HIGHLIGHTS OF PRESCRIBING INFORMATION First-Line Non Squamous ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Avastin, in combination with paclitaxel and cisplatin or paclitaxel and topotecan, is indicated for the treatment of patients with persistent, recurrent, or metastatic cervical cancer. ... Retrieve Full Source

HIGHLIGHTS OF PRESCRIBING INFORMATION These Highlights Do Not ...
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE ZOFRAN is indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m2 initial and repeat courses of moderately emetogenic cancer chemotherapy ... Read Full Source

Taxotere Prescribing Information - Home - Sanofi
TAXOTERE in combination with cisplatin and fluorouracil is indicated for the treatment of patients with advanced gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, who have not received prior chemotherapy for advanced disease. ... Document Retrieval

Followed By cisplatin 75 Mg/m (2.2) With 5 Mg Prednisone ...
See full prescribing information for complete boxed warning • GC: 75 mg/m2 followed by cisplatin 75 mg/m2 (both on day 1 only) followed by fluorouracil 750 mg/m2 per day as a 24-hr IV (days 1–5), starting at end of cisplatin infusion (2.4) ... Read Here

Package Insert Of Accord Healthcare’s Cisplatin Injection, 1 ...
Accord Healthcare, Inc. Cisplatin Injection 1 mg/mL Module 1.14.2.3 1.14.2.3 Final labeling text Package Insert of Accord Healthcare’s Cisplatin Injection, 1 mg/mL, 50 mL and 100 mL is enclosed in this section. ... Document Retrieval